For instance, carcinoembryonic antigen (CEA), as the only FDA-approved biomarker for colorectal cancer (CRC), is a selective biomarker for detecting disease recurrence and monitoring response to routine treatment 10, 11. The gene discussed is CEACAM5; the disease is colorectal carcinoma.